Tyler Korman: How is eXoZymes uniquely positioned to take advantage of AI?
videoscience
Tyler Korman: How is eXoZymes uniquely positioned to take advantage of AI?November 11, 2025
2025 Q3 Earnings Call
press releaseinvestor
eXoZymes to host third quarter 2025 update on Thursday November 13, 2025, at 5PM ESTNovember 10, 2025
CEO of eXoZymes on ‘AI in Life Sciences’ panel at the Beryl Elites’ Investment Conference
heltzeninvestor
CEO of eXoZymes on ‘AI in Life Sciences’ panel at the Beryl Elites’ Investment ConferenceOctober 30, 2025
Spartan Capital Annual Investor Conference
heltzeninvestor
CEO of eXoZymes to Present at Spartan Capital Securities’ Second Annual Investor ConferenceOctober 29, 2025
CEO of eXoZymes to Present at ThinkEquity’s Annual Investor Conference
heltzeninvestor
CEO of eXoZymes to Present at ThinkEquity’s Annual Investor ConferenceOctober 23, 2025
Lightning Rx, Colette Nataf
press clippings
Podcast: Lightning Rx' Colette Nataf interviews CEO Heltzen on future of biomanufacturingOctober 22, 2025
Podcast: 'The Catalyst' interviews CEO, Michael Heltzen
heltzenpress clippings
Podcast: 'The Catalyst' interviews CEO, Michael HeltzenOctober 17, 2025
Zachary Karl, Vice President Business Development @ Bio Innovations Midwest 2025
press clippingsvideo
World Bio Markets: AI - A tool U.S. industrial biomanufacturing cannot ignoreOctober 8, 2025
Inside Biotech podcast interviews CEO, Michael Heltzen
heltzenpress clippings
Podcast: 'Inside Biotech' interviews CEO, Michael HeltzenOctober 2, 2025
CCO Damien Perriman and co-founder and VP of Development, Dr. Paul Opgenorth.
press releasescience
Driving the cell-free revolution: eXoZymes leaders join BioMADE Leadership & Technical CommitteesSeptember 30, 2025
Previous page
Page 3 of 11
Next page